National Program of Cancer Registries Cancer Surveillance System - Standard CSS Report

Attachment 3a
Data Items by Diagnosis Year 1995-2013

Record ID and Demographic Section—(Name and [Number])
Record Type [10]
Patient ID Number [20] (unique)
Registry ID [40]
NAACCR Record Version [50]
Address at Dx—State [80]
1
County at Dx [90]
1
Rural-Urban Continuum/Beale Code 1993 [3300]
Rural-Urban Continuum/Beale Code 2003 [3310]1
Rural-Urban Continuum/Beale Code 2013 [2220]1
Address at Dx—Postal Code [100]
Census Tract 1970/80/90 [110]
Census Cod Sys 1970/80/90 [120]
2
Census Tract 2000 [130]
Census Tract 2010 [135]2
Census Tr Cert 1970/80/90 [364]
Census Tr Certainty 2000 [365]2
Census Tr Certainty 2010 [367]2
Race 1 [160]
Race 2 [161]
Spanish/Hispanic Origin [190]
NHIA Derived Hisp Origin [191]3
IHS Link [192]4
Race--NAPIIA [193]3
Sex [220]
Age at Diagnosis [230]
Date of Birth [240]
Date of Birth Flag [241]
Birthplace State [252]
Birthplace Country [254]
Census Occ Code 1970-2000 [270]20
Census Ind Code 1970-2000 [280]20
Occupation Source [290]20
Attachment 2a-1
August 2011
NPCR-CSS 2012 Data Submission

Required Status
1995–2013
Y
Y
Y
Y
Y
1
Y
1
Y
Y1
Y1
Y
Y
Y
2
Y
Y2
Y
Y2
Y2
Y
Y
Y
Y3
Y4
Y3
Y
Y
Y
Y
Y
Y
20
Y CER only
Y20 CER only
Y20 CER only

20

20

Industry Source [300]
20
Census Occ/Ind Sys 70-00 [330]
20
Text--Usual Occupation [310]
20
Text--Usual Industry [320]
Cancer Identification Section—(Name and [Number])
Sequence Number—Central [380]
Date of Diagnosis [390]
Date of Diagnosis Flag [391]
Primary Site [400]
Laterality [410]
Grade [440]
Diagnostic Confirmation [490]
Type of Reporting Source [500]
Casefinding Source [501]19

Y CER only
20
Y CER only
20
Y CER only
20
Y CER only
Required Status
1995–2013
Y
Y
Y
Y
Y
Y
Y
Y
As available19

Histologic Type ICD-O-3 [522]5
Behavior Code ICD-O-3 [523]5

Y5
Y5

Primary Payer at DX [630]14
Treatment First Course Section—(Name and [Number])
Date of Initial Rx—SEER [1260]6

As available14
Required Status
1995–2013
Y6

Date of Initial Rx Flag [1261]6

Y

Date of 1st Crs Rx—COC [1270]6

Y

Date of 1st Crs Rx Flag [1271]6

Y6

6
6

RX Date--Surgery [1200]20

Y20 CER only

RX Date--Surgery Flag [1201]20

Y CER only
7
Y

Rx Summ—Surg Primary Site [1290]

20

7

Rx Summ—Scope Reg LN Sur [1292]7

Y7

Rx Summ—Surg Oth Reg/Dis [1294]7

Y7

Reason for No Surgery [1340]

7

7

Y

RX Date--Radiation [1210]20

Y20 CER only

RX Date--Radiation Flag [1211]20
RX Summ—Radiation [1360]7

Y20 CER only
Y7

Reason for No Radiation [1430]20
RX Summ—Surg/Rad Seq [1380]7

Y20 CER only
Y7

RX Date--Chemo [1220]20

Y20 CER only

RX Date--Chemo Flag [1221]20
Rx Summ—Chemo [1390]7

Y20 CER only
Y7

RX Date--Hormone [1230]20

Y20 CER only

RX Date--Hormone Flag [1231]20

Y20 CER only

Attachment 2a-2
August 2011
NPCR-CSS 2012 Data Submission

Rx Summ—Horm [1400]

7

7

Y

RX Date--BRM [1240]20

20

Y CER only
20

20

RX Date--BRM Flag [1241]
Rx Summ—BRM [1410]7

Y CER only
7
Y

20

RX Date--Other [1250]

Y20 CER only

RX Date--Other Flag [1251]20

Y CER only
Y7

Rx Summ—Other [1420]

20

7

Rad—Regional Rx Modality [1570]

7

7

Y

RX Summ—Systemic/Sur Seq [1639]7

Y

7

Y

RX Summ--Transplant/Endocr [3250]

7
7

7, 20

7, 20

RX Summ--Treatment Status [1285]
RX Coding System Current [1460]20

Stage/Prognostic Factors Section—(Name and [Number])
Regional Nodes Positive [820]18
Regional Nodes Examined [830]18
SEER Summary Stage 2000 [759]

8

SEER Summary Stage 1977 [760]8
Lymph-Vascular Invasion [1182]20
CS Tumor Size [2800]9
CS Extension [2810]10

Y
20

Y CER only
Required Status
1995–2013
18
Y
Y18
8

Y

Y8
Y20 CER only
Y9
Y10

CS Tumor Size/Ext Eval [2820]

10

10

Y

CS Lymph Nodes [2830]10

Y10

CS Lymph Nodes Eval [2840]11

Y11

CS Mets at DX [2850]10

Y10

CS Mets Eval [2860]11
CS Site-Specific Factor 1 [2880] for:
C50 (breast)10
C70.0-C70.9, C71.0-C71.9, C72.0-C72.9, C75.1-C75.3 (brain,
CNS)11

Y10
Y10
Y11

C34 (lung)10

Y10

C384 (pleura)13

Y13

C692 with 9510/3, 9511/3, 9512/3, 9513/3 (retinoblastoma)10
Histologies 9950, 9961, 9962 (Polycythemia vera, Myelosclerosis
with myeloid metaplasia, Essential thrombocythemia)20
CS Site-Specific Factor 2 [2890] for:
C50 (breast)10
C54, C55 (corpus uteri)10

Y10
Y20 CER only
Y10
Y10

Attachment 2a-3
August 2011
NPCR-CSS 2012 Data Submission

13

13

CS Site-Specific Factor 3 [2900] for C619 (prostate)

Y

12

Y

12

CS Site-Specific Factor 15 [2869] for breast (C50)
CS Site-Specific Factor 25 [2879]

10

10

Y

CS Site-Specific Factors needed to derive AJCC Stage Group
CS Version Input Original [2935]
CS Version Derived [2936]
CS Version Input Current [2937]
13
Derived SS2000 [3020]
Over-ride CS 20 [3769]

20, 22

20, 22

Y

17

CER only
Y
Y
Y
13
Y
17

Y

AJCC TNM Path Stage Group [910]

14

14

As available

AJCC TNM Clin Stage Group [970]14
Derived AJCC 6th Edition Stage Group [3000]

As available14
14

14

As available

20

20

Derived AJCC-7 T [3400]

Y CER only

Derived AJCC-7 T Descript [3402]20

Y20 CER only

Derived AJCC-7 N [3410]20

Y CER only

20

20

Derived AJCC-7 N Descript [3412]

Y20 CER only

Derived AJCC-7 M [3420]20

Y20 CER only

Derived AJCC-7 M Descript [3422]20

Y20 CER only
14
As available ,
Y20 CER only

14, 20

Derived AJCC 7th Edition Stage Group [3430]
Comorbid/Complication 1 [3110]

20

Y20 CER only

Comorbid/Complication 2 [3120]20

Y20 CER only

Comorbid/Complication 3 [3130]20

Y20 CER only

Comorbid/Complication 4 [3140]20

Y CER only

Comorbid/Complication 5 [3150]20

Y20 CER only

Comorbid/Complication 6 [3160]

20

Y20 CER only

Comorbid/Complication 7 [3161]20

Y20 CER only

Comorbid/Complication 8 [3162]20

Y20 CER only

Comorbid/Complication 9 [3163]20

Y20 CER only

Comorbid/Complication 10 [3164]20

Y20 CER only

Source Comorbidity [9970]20, 21
Height [9960]20, 21
Weight [9961]20, 21
Tobacco Use Cigarettes [9965]20, 21
Tobacco Use Smoke [9966]20, 21
Tobacco Use Smokeless [9967]20, 21
Tobacco Use NOS [9968]20, 21
Follow-Up/Recurrence/Death Section—(Name and [Number])
Attachment 2a-4
August 2011
NPCR-CSS 2012 Data Submission

20

Y20, 21 CER only
Y20, 21 CER only
Y20, 21 CER only
Y20, 21 CER only
Y20, 21 CER only
Y20, 21 CER only
Y20, 21 CER only
Required Status
1995–2013

Date of Last Contact [1750]
Date of Last Contact Flag [1751]
Vital Status [1760]

Y
Y
Y
As available15

Follow-Up Source [1790]
Follow-Up Source Central [1791]
Cause of Death [1910]
ICD Revision Number [1920]

Attachment 2a-5
August 2011
NPCR-CSS 2012 Data Submission

15

Y
Y
Y

Over-Rides/Conversion/System Admin. Section—(Name and [Number])
Over-Ride Age/Site/Morph [1990]
Over-Ride SeqNo/DxConf [2000]
Over-Ride Site/Lat/Sequence Number [2010]
Over-Ride Surg/Dxconf [2020]
Over-Ride Site/Type [2030]
Over-Ride Histology [2040]
Over-Ride Report Source [2050]
Over-Ride Ill-define Site [2060]
Over-Ride Leuk, Lymphoma [2070]
Over-Ride Site/Behavior [2071]
Over-Ride Site/Lat/Morph [2074]
20, 21
CER Over-Ride [9969]
NPCR Site-Specific Factors
EDP MDE Link Variable [Subm]

16

EDP MDE Link Date [Subm]16

Required Status
1995–2013
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y20, 21 CER only
Required Status
1995–2013
16
Y
Y16

NOTES:
Shaded items denote variables that are considered advanced surveillance data. Non-shaded variables denote
core surveillance data.
Data items new to this submission or having a status change are noted in bold.
The data item names and numbers are those used in NAACCR Volume II, Version 12.2.
Status key: Y = Yes
1

Code “999” for unknown and invalid. Do not include cases with code “998” in the submission file. If State
law precludes the registry from identifying specific counties on a file of individual records, recode all valid
county codes to “000” and convert county codes to the derived Rural Urban Continuum variables. The Rural
Urban Continuum 2013 is to be submitted in columns 2345-2346. See Submission Specifications document
for more details.
2

Census Tract 2000 [130] is recommended for reportable cases diagnosed in 1998-2002 and required for
reportable cases diagnosed in 2003 and later. Census Tract 2010 [135] is required for reportable cases
diagnosed in 2010 and later. Census Tract 2010 is required for CER Specialized Registries.
3

Report the results from the combined NHIA/NAPIIA (NHAPIIA) SAS Program. See the Submission
Specifications document and/or Atachment 1 for more details. Please note that code 9, unknown, is not a
valid code for the NHIA data item.
4

Report the results of cases submitted for IHS linkage using codes 0 or 1. See the Submission Specifications
document for further details.

5

For reportable cases diagnosed in 2001 or later, data should be coded using the ICD-O-3 manual and
submitted with these original ICD-O-3 values. For reportable cases diagnosed before 2001, data should be
coded using the ICD-O-2 manual. Prior to submission, convert these ICD-O-2 codes to ICD-O-3 codes.
Attachment 2a-6
August 2011
NPCR-CSS 2012 Data Submission

6

Submit either the SEER or COC field; for reportable cases diagnosed prior to 2006, as available.

7

For reportable cases diagnosed prior to 2006, submit as available. For Rad–Regional Rx Modality, cases
diagnosed from 2003-2006, submit as available. For all cases diagnosed on or after January 1, 2012,
NPCR continues to require collection of the data items related to surgery of the primary site; RX Summ-Surg Prim Site [1290], RX Summ--Scope Reg LN Sur [1292], RX Summ--Surg Oth Reg/Dis [1294],
Reason for No Surgery [1340]. All other treatment modalities (radiation, chemo, hormone, BRM, etc)
are “Required When Available” for diagnosis year 2012 forward. For breast, colon, and rectum cases
diagnosed on or after January 1, 2012, NPCR continues to require collection of all treatment modalities .
CCRs should consolidate all surgery data before submission to CDC.
8

For reportable cases diagnosed prior to 2001, code using SEER Summary Staging Guide 1977. For
reportable cases diagnosed in 2001 and later, code using SEER Summary Staging Manual 2000. Report
Summary Stage 2000 as available for diagnosis years 2004 and later.
9

For reportable cases diagnosed 2008 and later, CS Tumor Size [2800] is required. For cases diagnosed prior
to 2008, submit as available.
10

For reportable cases diagnosed 2010 and later, CS Extension, CS Tumor Size/Ext Eval, CS Lymph Nodes,
CS Mets at DX, SSF1 for breast, lung, and retinoblastoma, SSF2 for breast and corpus uteri, and SSF25 are
required. For cases diagnosed 2004-2009, submit as available.
11

For reportable cases diagnosed 2011 and later, CS Lymph Nodes Eval, CS Mets Eval, and SSF1 for
brain/CNS is required. For cases diagnosed 2004-2010, submit as available.
12
For reportable cases diagnosed 2011 and later, SSF15 is required. For cases diagnosed 2010, submit as
available.
13
For reportable cases diagnosed in 2004 and later, SSF1 for pleura, SSF3 for prostate, and Derived Summary
Stage 2000 [3020] is required.
14

For reportable cases diagnosed 1995-2012, submit as available.
For reportable cases diagnosed 2006 and later, Follow-Up Source Central [1791] is required. For cases
diagnosed prior to 2006, Follow-Up Source [1790] submit as available.
15

16

For linkage results of reportable breast, cervical, and colorectal cancer cases. Report the EDP MDE Link
Variable in column 1306 and the EDP MDE Link Date in columns 1307-1314 as instructed in the 2014 NPCRCSS Submission Specifications.
17

Over-Ride CS 20 [3769] is designated as a flag to identify cases directly coded using SEER Summary Stage
2000 [759]. Use code 1 to indicate when SEER Summary Stage 2000 is directly coded, rather than derived
using the Collaborative Staging Data Collection System. Otherwise, “Over-Ride CS 20” must be blank.
18
For reportable COLORECTAL CANCER CASES ONLY; submit Regional Nodes Positive [820] and
Regional Nodes Examined [830] as available for diagnosis years 1995-2011. For diagnosis year 2012 and
later, Regional Nodes Positive [820] and Regional Nodes Examined [830] are required for all sites.

Attachment 2a-7
August 2011
NPCR-CSS 2012 Data Submission